0001104659-18-013697.txt : 20180228 0001104659-18-013697.hdr.sgml : 20180228 20180228213251 ACCESSION NUMBER: 0001104659-18-013697 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180226 FILED AS OF DATE: 20180228 DATE AS OF CHANGE: 20180228 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Bergstein Ivan CENTRAL INDEX KEY: 0001554767 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35619 FILM NUMBER: 18654454 MAIL ADDRESS: STREET 1: C/O STEMLINE THERAPEUTICS, INC. STREET 2: 750 LEXINGTON AVENUE, 6TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: STEMLINE THERAPEUTICS INC CENTRAL INDEX KEY: 0001264587 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 450522567 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 750 LEXINGTON AVENUE STREET 2: ELEVENTH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 646-502-2311 MAIL ADDRESS: STREET 1: 750 LEXINGTON AVENUE CITY: NEW YORK STATE: NY ZIP: 10022 4 1 a4.xml 4 X0306 4 2018-02-26 0 0001264587 STEMLINE THERAPEUTICS INC STML 0001554767 Bergstein Ivan C/O STEMLINE THERAPEUTICS, INC. 750 LEXINGTON AVENUE, ELEVENTH FLOOR NEW YORK NY 10022 1 1 0 0 Chief Executive Officer Common Stock 2018-02-26 4 S 0 10776 17.61 D 2070784 D Common Stock 2018-02-27 4 S 0 13407 17.26 D 2057377 D In connection with the vesting of 44,521 shares on February 24, 2018, a total of 24,183 of such shares were sold by the Company in order to satisfy the reporting person's tax withholding obligations. The reporting person had no discretion with respect to such sale, which was conducted automatically in accordance with the issuer's corporate policies. Reflects the weighted average sale price. The range of prices for such transaction is $17.60 to $17.80. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. Of the 2,070,784 shares, 380,456 are restricted stock. Reflects the weighted average sale price. The range of prices for such transaction is $17.00 to $17.50. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. Of the 2,057,377 shares, 380,456 are restricted stock. /s/ Ivan Bergstein 2018-02-28